Lessons Learned from Fibromyalgia

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive of the live session held at the 2010 Spring Managed Care Forum. If you participated in the live activity, you are not eligible for continuing education credits from this archive.

This activity is valid from July 25, 2011 to July 25, 2012
These presentations require Internet Explorer 5.0 or later, Netscape Navigator 7.0 or later, or Internet Explorer 5.2.2 for Mac.  To Download the latest version of Internet Explorer from the Microsoft web site, click here.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Forest Laboratories and Pfizer Inc
 
PLEASE CLICK HERE TO VIEW THE PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU: Read the article, answer the post test, complete the evaluation form, and hit submit. A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or you can fax them to Katie Eads at 804-747-5316.

Description
Fibromyalgia, a predominately centrally medicated chronic pain state, can be used to illustrate the advances that have been made in understanding and treating chronic pain. Because central chronic pain is caused by alterations in pain perception and modulation, therapy needs to target central nervous system neurotransmitters. Therapy with nonpharmacologic interventions also is necessary to manage the functional consequences of pain and psychological factors.

Upon Completion of this activity, participants will be able to:

  • Discuss how current paradigms for diagnosing and treating chronic pain are obsolete and need to change.

  • Identify the role central neuronal factors play in inter-individual differences in pain sensitivity and are present in all chronic pain states.

  • Discuss how central mechanisms of pain are prominent in FM, irritable bowel syndrome, temporomandibular joint disease, and tension headache.

Faculty: Daniel J. Clauw, MD
Professor of Anesthesiology, Medicine (Rheumatology) and Psychiatry
Director, Chronic Pain and Fatigue Research Center
The University of Michigan

Disclosure:

 Dr. Clauw is a consultant for Pfizer, Forest, Eli Lilly, Pierre Fabre, Cypress Biosciences, Wyeth, UCB, and Astra Zeneca. He also receives research support from Pfizer, Cypress Biosciences, and Forest. Dr. Clauw received a one-time licensing fee paid to the University of Michigan by Eli Lilly, and has gotten funding from multiple NIH grants.
  Planning Committee:
 Bill Williams, MD has no real or perceived financial relationships to disclose.
 Katie Eads has no real or perceived financial relationships to disclose.
NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA). VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.
   

This activity is supported by an educational grant from Forest Laboratories and Pfizer Inc
 

NAMCP and or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.